en
svPress releases
Press release 2019-12-19
First batch of HyNap-Dasa tablets manufactured on commercial scale according to GMP
Regulatory press release 2019-12-05
Xspray Pharma has carried out a directed share issue raising gross proceeds of approximately SEK 122 million
Regulatory press release 2019-12-05
Xspray Pharma contemplates a directed share issue
Press release 2019-11-14
Xspray Pharma publishes Interim Report Q3, January – September 2019
Regulatory press release 2019-10-31
Xspray receives FDA clearance of IND for HyNap-Dasa
Press release 2019-10-04
Xspray – Successful submission of IND application to FDA
Press release 2019-09-10
Xspray aims for up-listing first half of 2020
Press release 2019-08-29
Xspray Pharma publishes Interim Report Q2, January – June 2019
Regulatory press release 2019-06-27
Successful production start for HyNap-Dasa in Xspray’s unique full-scale production line
Regulatory press release 2019-06-11